Split Verdict In Merck Vioxx Trial
A New Jersey jury found Merck & Co. (MRK) liable for the heart attack of one former Vioxx user while exonerating the company in the heart attack of the second plaintiff in the case. The stock price dropped $1.15 to close at $34.84.
0 Comments:
Post a Comment
<< Home